R&D Sponsored Innovative sublingual medication for improved stroke care Stroke poses a major threat to public health, and this threat is predicted to worsen in the years to come.
News Despite study bust, Vistagen still hopes to file anxiety dru... Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.